RANGWALA RESHMA (EVP & Chief Medical Officer) received a stock award from KARYOPHARM THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001193125-26-035682
Officer· EVP & Chief Medical Officer
Since Apr 2022
+32.41K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
32.41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32.41K
Price / share
—
Trade value
—
% of position
110.3%
1/31/2026
29.39K→61.80K
Total
Net shares
+32.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | A · Award | +32.41K | — | — | 110.3% | 29.39K | 61.80K |
| Total | +32.41K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported